neuromyelitis optica spectrum disorder

Showing 1 - 25 of 32

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Neuromyelitis Optica Spectrum Disorder, NMOSD, AQP4+ NMOSD Trial

Not yet recruiting
  • Neuromyelitis Optica Spectrum Disorder
  • +2 more
    • (no location specified)
    Jul 21, 2023

    Neuromyelitis Optica Spectrum Disorder Exposed to UPLIZNA®

    Not yet recruiting
    • Neuromyelitis Optica Spectrum Disorder
    • Pregnancy Related
    • (no location specified)
    Jun 9, 2023

    Inebilizumab in Acute Neuromyelitis Optica Spectrum Disorders

    Not yet recruiting
    • Neuromyelitis Optica Spectrum Disorder
    • (no location specified)
    Jun 5, 2023

    Neuromyelitis Optica Spectrum Disorder Trial in Worldwide (Inebilizumab)

    Recruiting
    • Neuromyelitis Optica Spectrum Disorder
    • La Jolla, California
    • +14 more
    Jan 25, 2023

    Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Neuromyelitis Optica Spectrum Disorder Trial in Wuhan (CT103A

    Recruiting
    • Autoimmune Diseases
    • +5 more
    • CT103A cells
    • Cyclophosphamide and fludarabine
    • Wuhan, Hubei, China
      Tongji Hospital affiliated to Tongji Medical College of Huazhong
    Dec 10, 2022

    Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorder, NMO Spectrum Disorder Trial in Tianjin (Daratumumab, Placebo)

    Recruiting
    • Neuromyelitis Optica
    • +2 more
    • Tianjin, Tianjin, China
      Tianjin Medical University General Hospital
    Oct 19, 2022

    Immune Cells and Meningeal Lymphatic Drainage in Demyelinating

    Recruiting
    • Multiple Sclerosis
    • +2 more
    • Tianjin, Tianjin, China
      Tianjin Medical University General Hospital
    Oct 19, 2022

    Neuromyelitis Optica Spectrum Disorder Trial (Mitoxantrone Hydrochloride Liposome Injection)

    Not yet recruiting
    • Neuromyelitis Optica Spectrum Disorder
    • Mitoxantrone Hydrochloride Liposome Injection
    • (no location specified)
    Sep 20, 2022

    Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorder Trial in Worldwide (eculizumab)

    Completed
    • Neuromyelitis Optica
    • Neuromyelitis Optica Spectrum Disorder
    • eculizumab
    • Scottsdale, Arizona
    • +68 more
    Jul 25, 2022

    Neuromyelitis Optica Spectrum Disorder, NMOSD Trial in Le Kremlin-bicêtre, Gdansk (Satralizumab)

    Recruiting
    • Neuromyelitis Optica Spectrum Disorder
    • NMOSD
    • Le Kremlin-bicêtre, France
    • +1 more
    Aug 17, 2022

    Neuromyelitis Optica Spectrum Disorder Trial in Xi'an (Ofatumumab)

    Recruiting
    • Neuromyelitis Optica Spectrum Disorder
    • Xi'an, Shaanxi, China
      Tangdu Hospital
    Aug 16, 2022

    Neuromyelitis Optica Spectrum Disorder Trial in Barcelona (Ravulizumab)

    Recruiting
    • Neuromyelitis Optica Spectrum Disorder
    • Barcelona, Spain
      Clinical Trial Site
    Jul 6, 2022

    Neuromyelitis Optica Spectrum Disorder Trial in Beijing (MIL62, Placebo)

    Not yet recruiting
    • Neuromyelitis Optica Spectrum Disorder
    • (no location specified)
    May 26, 2022

    Rare Neuroimmunologic Disorders

    Recruiting
    • Neuromyelitis Optica
    • +3 more
      • Dallas, Texas
        The University of Texas Southwestern Medical Center
      May 9, 2022

      Sclerosis, Multiple, Neuromyelitis Optica Spectrum Disorder, Myelin Oligodendrocyte Glycoprotein (MOG)-Antibody Related

      Recruiting
      • Sclerosis, Multiple
      • +3 more
      • No intervention
      • Amiens, France
      • +33 more
      Mar 21, 2022

      Neuromyelitis Optica Spectrum Disorder Trial in Worldwide (satralizumab, azathioprine (AZA), mycophenolate mofetil (MMF))

      Active, not recruiting
      • Neuromyelitis Optica Spectrum Disorder
      • Birmingham, Alabama
      • +52 more
      Mar 16, 2022

      Neuromyelitis Optica Spectrum Disorder Trial in Beijing (Orelabrutinib)

      Not yet recruiting
      • Neuromyelitis Optica Spectrum Disorder
      • Beijing, Beijing, China
        Peking Union Medical College Hospital, Chinese Academy of Medica
      Mar 16, 2022

      Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorder Trial in Worldwide (Ravulizumab)

      Active, not recruiting
      • Neuromyelitis Optica
      • Neuromyelitis Optica Spectrum Disorder
      • Ravulizumab
      • Birmingham, Alabama
      • +67 more
      Feb 3, 2022

      Maintenance Plasma Exchange for Neuromyelitis Optica

      Completed
      • Neuromyelitis Optica
      • +2 more
      • Plasma exchange (PLEX)
      • Scottsdale, Arizona
      • +1 more
      Dec 7, 2021

      Optic Neuritis, Transverse Myelitis, Acute Disseminated Encephalomyelitis Trial in Switzerland

      Recruiting
      • Optic Neuritis
      • +16 more
        • Aarau, Aargau, Switzerland
        • +11 more
        Aug 18, 2021

        Neuromyelitis Optica Spectrum Disorder Trial in Waltham

        Enrolling by invitation
        • Neuromyelitis Optica Spectrum Disorder
          • Waltham, Massachusetts
            Corrona, LLC
          May 10, 2021

          Clinical Patterns of Neuromyelitis Optica Spectrum Disorders in

          Completed
          • Neuromyelitis Optica Spectrum Disorder
          • serum aquaporin 4 antibody (AQP-4-Ab)
          • +2 more
          • Assiut, Egypt
            Assiut University Hospital
          Nov 5, 2020

          Neuromyelitis Optica Spectrum Disorder Trial (Rituximab)

          Completed
          • Neuromyelitis Optica Spectrum Disorder
          • (no location specified)
          Oct 14, 2020

          Neuromyelitis Optica Spectrum Disorder Trial in Isfahan (Azathioprine, Rituximab)

          Completed
          • Neuromyelitis Optica Spectrum Disorder
          • Isfahan, Iran, Islamic Republic of
            Kashani Hospital
          Sep 29, 2020

          Neuromyelitis Optica Spectrum Disorder Trial in Beijing (Corticosteroids & tanCART19/20)

          Withdrawn
          • Neuromyelitis Optica Spectrum Disorder
          • Corticosteroids & tanCART19/20
          • Beijing, Beijing, China
            People's Liberation of Army General Hospital (PLAGH)
          Sep 17, 2019